Scientists at Northwestern University in Illinois have, for the first time, been able to quantify the concentrations of chemotherapy drug in the human brain after the device was used to temporarily open the blood-brain barrier.

Scientists have identified more than 200 genes that work together to drive the growth of glioblastoma, an aggressive type of brain cancer.